mitomycin has been researched along with Esophageal Atresia in 5 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Esophageal Atresia: Congenital abnormality characterized by the lack of full development of the ESOPHAGUS that commonly occurs with TRACHEOESOPHAGEAL FISTULA. Symptoms include excessive SALIVATION; GAGGING; CYANOSIS; and DYSPNEA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the present study was to evaluate the efficacy and short-term safety of topical mitomycin-C, an antifibrotic agent, in preventing the recurrence of anastomotic strictures after surgical repair of esophageal atresia (EA)." | 7.80 | Topical mitomycin-C application in recurrent esophageal strictures after surgical repair of esophageal atresia. ( Chapuy, L; Faure, C; Pomerleau, M, 2014) |
| "The aim of the present study was to evaluate the efficacy and short-term safety of topical mitomycin-C, an antifibrotic agent, in preventing the recurrence of anastomotic strictures after surgical repair of esophageal atresia (EA)." | 3.80 | Topical mitomycin-C application in recurrent esophageal strictures after surgical repair of esophageal atresia. ( Chapuy, L; Faure, C; Pomerleau, M, 2014) |
| "Refractory esophageal stenosis (RES) is a major health problem in the pediatric population." | 1.43 | Management of refractory esophageal stenosis in the pediatric age. ( Alberca de Las Parras, F; Egea Valenzuela, J; Navalón Rubio, M, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapuy, L | 1 |
| Pomerleau, M | 1 |
| Faure, C | 1 |
| Manfredi, MA | 1 |
| Alberca de Las Parras, F | 1 |
| Navalón Rubio, M | 1 |
| Egea Valenzuela, J | 1 |
| Heran, MKS | 1 |
| Pham, TH | 1 |
| Butterworth, S | 1 |
| Robinson, A | 1 |
| Michaud, L | 1 |
| Gottrand, F | 1 |
1 review available for mitomycin and Esophageal Atresia
| Article | Year |
|---|---|
Endoscopic Management of Anastomotic Esophageal Strictures Secondary to Esophageal Atresia.
Topics: Alkylating Agents; Deglutition Disorders; Dilatation; Esophageal Atresia; Esophageal Stenosis; Esoph | 2016 |
4 other studies available for mitomycin and Esophageal Atresia
| Article | Year |
|---|---|
Topical mitomycin-C application in recurrent esophageal strictures after surgical repair of esophageal atresia.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Child; Child, Preschool; Constriction, Patholo | 2014 |
Management of refractory esophageal stenosis in the pediatric age.
Topics: Adolescent; Antibiotics, Antineoplastic; Child; Child, Preschool; Drug Resistance; Esophageal Atresi | 2016 |
Use of a microporous polytetrafluoroethylene catheter balloon to treat refractory esophageal stricture: a novel technique for delivery of mitomycin C.
Topics: Administration, Topical; Alkylating Agents; Catheterization; Equipment Design; Esophageal Atresia; E | 2011 |
Anastomotic strictures: conservative treatment.
Topics: Anastomosis, Surgical; Antibiotics, Antineoplastic; Constriction, Pathologic; Esophageal Atresia; Hu | 2011 |